$ Value
$0
Shares
99,517
Price
$0
Filed
Feb 3
Insider
Name
Sommadossi Jean-Pierre
Title
President, CEO, and Chairman
CIK
0001296995
Roles
Transaction Details
Transaction Date
2026-01-31
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. | The original grant of 520,400 RSUs vested in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs were fully vested as of January 31, 2026. | Reflects RSUs following the satisfaction of performance criteria of previously granted performance restricted stock units that vested on January 31, 2026. | Reflected one (1) share correction due to prior administrative rounding error with respect to RSU vesting in 2026. | The option is fully vested and exercisable.
Filing Info
Sommadossi Jean-Pierre's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-03 | AVIR | M | $372K |
| 2026-02-03 | AVIR | M | $0 |
| 2026-01-31 | AVIR | M | — |
| 2026-01-31 | AVIR | F | $450K |
| 2026-01-31 | AVIR | M | $0 |
| 2026-01-31 | AVIR | M | $0 |
Other Insiders at AVIR (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Sommadossi Jean-Pierre
President, CEO, and Chairman
|
— | — | 2026-02-03 |
|
Corcoran Andrea
See Remarks
|
— | — | 2026-01-31 |
|
Foster Wayne
EVP, Chief Accounting Officer
|
— | — | 2026-01-31 |
|
Horga Maria Arantxa
Chief Medical Officer
|
— | — | 2026-01-31 |
|
Vavricka John
Chief Commercial Officer
|
— | — | 2026-01-31 |
|
Hammond Janet MJ
Chief Development Officer
|
— | — | 2026-01-31 |